ICP
TMO icon

Interchange Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Interchange Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$592K Buy
1,189
+119
+11% +$64.6K 0.19% 117
2025
Q4 		$620K Sell
1,070
-8
-0.7% -$4.52K 0.12% 163
2025
Q3 		$524K Buy
1,078
+94
+10% +$43.8K 0.1% 173
2025
Q2 		$399K Sell
984
-177
-15% -$74K 0.09% 175
2025
Q1 		$578K Buy
1,161
+9
+0.8% +$4.87K 0.16% 122
2024
Q4 		$603K Sell
1,152
-393
-25% -$216K 0.22% 115
2024
Q3 		$957K Sell
1,545
-26
-2% -$15.4K 0.34% 78
2024
Q2 		$869K Buy
1,571
+835
+113% +$478K 0.32% 83
2024
Q1 		$431K Buy
736
+21
+3% +$11.8K 0.29% 84
2023
Q4 		$380K Sell
715
-108
-13% -$52.3K 0.29% 87
2023
Q3 		$417K Buy
823
+144
+21% +$76.7K 0.33% 77
2023
Q2 		$355K Sell
679
-404
-37% -$218K 0.27% 93
2023
Q1 		$627K Buy
1,083
+636
+142% +$358K 0.34% 73
2022
Q4 		$246K Buy
447
+1
+0.2% +$530 0.25% 96
2022
Q3 		$226K Sell
446
-35
-7% -$19.6K 0.25% 126
2022
Q2 		$261K Sell
481
-9
-2% -$4.95K 0.29% 106
2022
Q1 		$289K Buy
+490
New +$281K 0.3% 111
2021
Q4 		– Sell
-756
Closed -$431K – 191
2021
Q3 		$431K Sell
756
-2
-0.3% -$1.1K 0.72% 51
2021
Q2 		$382K Sell
758
-72
-9% -$34K 0.59% 62
2021
Q1 		$393K Sell
830
-31
-4% -$14.8K 0.21% 146
2020
Q4 		$401K Buy
+861
New +$404K 0.22% 126

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Interchange Capital Partners's TMO Position: Q1 2026 in Review

Interchange Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, buying an estimated $64.6K and bringing the position to 1,189 shares worth $592K. The position accounts for 0.19% of the portfolio, ranked #117.

Interchange Capital Partners first reported a position in TMO in Q4 2020 and has held it in 21 quarters since. The position peaked at $957K in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Interchange Capital Partners held 1,189 shares of Thermo Fisher Scientific worth $592K as of Q1 2026.
  • Interchange Capital Partners bought 119 Thermo Fisher Scientific shares in Q1 2026, an estimated $64.6K.
  • Thermo Fisher Scientific made up 0.19% of Interchange Capital Partners's portfolio in Q1 2026, its #117 holding.
  • Interchange Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 21 quarters since.
  • Interchange Capital Partners's Thermo Fisher Scientific position peaked at $957K in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.